PIK3CA and triple-negative breast carcinoma: In this relation, it has already been demonstrated in triple negative breast cancer cell lines, that combining PI3K and EGFR inhibitors produces a better response than each inhibitor alone [63] becoming a promising strategy for BRCAness tumors treatment.